- Report
- September 2025
- 282 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 100 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 193 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 194 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 299 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 283 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 282 Pages
Global
From €5146EUR$5,850USD£4,465GBP
From €4311EUR$4,900USD£3,740GBP
- Report
- February 2025
- 182 Pages
Global
From €3959EUR$4,500USD£3,435GBP
- Report
- September 2025
- 396 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 566 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 181 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 93 Pages
Global
From €4926EUR$5,600USD£4,275GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1320EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1759EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 250 Pages
Global
From €2639EUR$3,000USD£2,290GBP
- Clinical Trials
- April 2025
- 100 Pages
Global
From €2639EUR$3,000USD£2,290GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1759EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1100EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 90 Pages
Global
From €1320EUR$1,500USD£1,145GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more